133 related articles for article (PubMed ID: 26926150)
21. A single-institution assessment of superficial spreading melanoma (SSM) in the pediatric population: Molecular and histopathologic features compared with adult SSM.
Verzì AE; Bubley JA; Haugh AM; Zhang B; Wagner A; Kruse L; West DP; Wayne J; Guitart J; Gerami P
J Am Acad Dermatol; 2017 Nov; 77(5):886-892. PubMed ID: 28754310
[TBL] [Abstract][Full Text] [Related]
22. Characteristics, treatment, and survival of invasive malignant melanoma (MM) in giant pigmented nevi (GPN) in adults: 976 cases from the National Cancer Data Base (NCDB).
Turkeltaub AE; Pezzi TA; Pezzi CM; Dao H
J Am Acad Dermatol; 2016 Jun; 74(6):1128-34. PubMed ID: 26899200
[TBL] [Abstract][Full Text] [Related]
23. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States.
Amini A; Rusthoven CG; Waxweiler TV; Jones BL; Fisher CM; Karam SD; Raben D
J Am Acad Dermatol; 2016 Feb; 74(2):309-16. PubMed ID: 26670715
[TBL] [Abstract][Full Text] [Related]
24. Tumor mitotic rate is an independent predictor of survival for nonmetastatic melanoma.
Evans JL; Vidri RJ; MacGillivray DC; Fitzgerald TL
Surgery; 2018 Sep; 164(3):589-593. PubMed ID: 29929753
[TBL] [Abstract][Full Text] [Related]
25. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
26. Malignant melanoma in the Czech Republic: incidence and mortality according to sex, age and disease stage.
Vranova J; Arenbergerova M; Arenberger P; Vrana A; Zivcak J; Kolarova H; Rosina J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):438-46. PubMed ID: 23128825
[TBL] [Abstract][Full Text] [Related]
27. Melanoma survival disadvantage in young, non-Hispanic white males compared with females.
Gamba CS; Clarke CA; Keegan TH; Tao L; Swetter SM
JAMA Dermatol; 2013 Aug; 149(8):912-20. PubMed ID: 23804160
[TBL] [Abstract][Full Text] [Related]
28. On the prognostic importance of white depressed areas in the primary lesion of superficial spreading melanoma.
McLean DI; Lew RA; Sober AJ; Mihm MC; Fitzpatrick TB
Cancer; 1979 Jan; 43(1):157-61. PubMed ID: 761159
[TBL] [Abstract][Full Text] [Related]
29. Conditional survival after surgical treatment of melanoma: an analysis of the Surveillance, Epidemiology, and End Results database.
Rueth NM; Groth SS; Tuttle TM; Virnig BA; Al-Refaie WB; Habermann EB
Ann Surg Oncol; 2010 Jun; 17(6):1662-8. PubMed ID: 20165985
[TBL] [Abstract][Full Text] [Related]
30. Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study.
Feigelson HS; Powers JD; Kumar M; Carroll NM; Pathy A; Ritzwoller DP
Cancer Med; 2019 Aug; 8(9):4508-4516. PubMed ID: 31215776
[TBL] [Abstract][Full Text] [Related]
31. Older Age is Associated with a Higher Incidence of Melanoma Death but a Lower Incidence of Sentinel Lymph Node Metastasis in the SEER Databases (2003-2011).
Cavanaugh-Hussey MW; Mu EW; Kang S; Balch CM; Wang T
Ann Surg Oncol; 2015 Jul; 22(7):2120-6. PubMed ID: 25940571
[TBL] [Abstract][Full Text] [Related]
32. Melanoma incidence rises for children and adolescents: an epidemiologic review of pediatric melanoma in the United States.
Austin MT; Xing Y; Hayes-Jordan AA; Lally KP; Cormier JN
J Pediatr Surg; 2013 Nov; 48(11):2207-13. PubMed ID: 24210187
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy is prognostic but not therapeutic for thick melanoma.
Kachare SD; Singla P; Vohra NA; Zervos EE; Wong JH; Fitzgerald TL
Surgery; 2015 Sep; 158(3):662-8. PubMed ID: 26096561
[TBL] [Abstract][Full Text] [Related]
35. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
36. Subtyping Cutaneous Melanoma Matters.
El Sharouni MA; van Diest PJ; Witkamp AJ; Sigurdsson V; van Gils CH
JNCI Cancer Spectr; 2020 Dec; 4(6):pkaa097. PubMed ID: 33409460
[TBL] [Abstract][Full Text] [Related]
37. Survival advantage of women in localized melanoma mainly relies on clinical-pathological differences by sex. A retrospective study of 1,607 patients in Valencia, Spain.
Kindem S; Garcías-Ladaria J; Requena C; Guillén C; Oliver V; Nagore E
Eur J Dermatol; 2015; 25(3):247-54. PubMed ID: 25961331
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous melanoma.
Armstrong BK; Kricker A
Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
[TBL] [Abstract][Full Text] [Related]
39. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).
Metelitsa AI; Dover DC; Smylie M; de Gara CJ; Lauzon GJ
J Am Acad Dermatol; 2010 Feb; 62(2):227-32. PubMed ID: 20018405
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland.
Montella A; Gavin A; Middleton R; Autier P; Boniol M
Eur J Cancer; 2009 Sep; 45(13):2360-6. PubMed ID: 19375307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
